Hongchang International Co., Ltd (HCIL) stock: key figures, P/E, revenue and dividend

Health Care · ISIN US42831T2024

Price
0.00 USD
Market cap
155,649.41 USD
P/E (2025)
–
P/S (2025)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

Hongchang International Co., Ltd financials

Fiscal year2024
Revenue2.87 m USD
Gross profit181,632.00 USD
Operating income-383,326.00 USD
EBIT-495,851.00 USD
Net income-472,393.00 USD
Diluted EPS – continuing operations0.00 USD

Full history since 2009, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Hongchang International Co., Ltd

Hongchang International Co., Ltd engages in the food trading and biotechnology businesses in China, the United States, and internationally. It offers technical and consultation services. The company is based in Fuzhou, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.